Next 10 |
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...
2024-05-12 12:40:00 ET Summary Riverwater Partners is a Milwaukee-based investment advisory firm dedicated to responsible investing. Our mission is to make the world a better place by growing wealth through sustainable investing. The Micro Opportunities Strategy underperformed its...
2024-05-07 12:52:06 ET Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Conference Call May 07, 2024, 08:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Particip...
2024-05-07 07:12:52 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Harvard Bioscience Q1 2024 Earnings Preview Seeking Alpha’s Quant...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Jim Green, Chairman and CEO, said, “As expected, our first quarter revenues reflect o...
2024-05-06 11:08:27 ET Major earnings expected before the bell on Tuesday include: BP p.l.c. ( BP ) Datadog ( DDOG ) The Walt Disney ( DIS ) Duke Energy ( DUK ) Nikola ( NKLA ) Read the full article on Seeking Alpha For further details...
2024-05-06 10:56:49 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Harvard Bioscience Historical ear...
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Par...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Exe...
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...